{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:29:14Z","timestamp":1773296954967,"version":"3.50.1"},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>\u00a9 2014 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2154","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T11:56:38Z","timestamp":1385639798000},"page":"24-28","source":"Crossref","is-referenced-by-count":27,"title":["Insights Into the Mechanisms of Sclerostin Action in Regulating Bone Mass Accrual"],"prefix":"10.1093","volume":"29","author":[{"given":"Bart O","family":"Williams","sequence":"first","affiliation":[{"name":"Center for Skeletal Disease and Tumor MetastasisVan Andel Research InstituteGrand RapidsMIUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"issue":"211","key":"2024020318592607700_jbmr2154-bib-0001","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/scitranslmed.3006627","article-title":"Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome","volume":"5","author":"Kedlaya","year":"2013","journal-title":"Sci Transl Med."},{"key":"2024020318592607700_jbmr2154-bib-0002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jbmr.2059","article-title":"Reversing LRP5-dependent osteoporosis and SOST-deficiency-induced sclerosing bone disorders by altering WNT signaling activity","volume":"29","author":"Chang","year":"2014","journal-title":"J Bone Miner Res."},{"key":"2024020318592607700_jbmr2154-bib-0003","first-page":"351","volume-title":"Handbuch der Kinderhidlkunde [Handbook of Disease Therapy for Children]","author":"Hansen","year":"1967"},{"key":"2024020318592607700_jbmr2154-bib-0004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1148\/13.1.44","article-title":"Generalized osteitis fibrosa","volume":"13","author":"Hirsch","year":"1929","journal-title":"Radiology."},{"key":"2024020318592607700_jbmr2154-bib-0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1302\/0301-620X.40B2.208","article-title":"Osteopetrosis with syndactyly: a morphological variant of Albers-Schonberg's disease","volume":"40","author":"Truswell","year":"1958","journal-title":"J Bone Joint Surg Br."},{"key":"2024020318592607700_jbmr2154-bib-0006","author":"Papapoulos"},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0007","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","article-title":"The natural history of sclerosteosis","volume":"63","author":"Hamersma","year":"2003","journal-title":"Clin Genet."},{"issue":"20","key":"2024020318592607700_jbmr2154-bib-0008","first-page":"783","article-title":"Sclerosteosis in South Africa","volume":"55","author":"Beighton","year":"1979","journal-title":"S Afr Med J."},{"issue":"1","key":"2024020318592607700_jbmr2154-bib-0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.1977.tb01269.x","article-title":"Sclerosteosis\u2014an autosomal recessive disorder","volume":"11","author":"Beighton","year":"1977","journal-title":"Clin Genet."},{"issue":"23","key":"2024020318592607700_jbmr2154-bib-0010","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin,a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO.J."},{"issue":"6","key":"2024020318592607700_jbmr2154-bib-0011","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/302416","article-title":"Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21","volume":"64","author":"Balemans","year":"1999","journal-title":"Am J Hum Genet."},{"issue":"5","key":"2024020318592607700_jbmr2154-bib-0012","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet."},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0013","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet."},{"issue":"7","key":"2024020318592607700_jbmr2154-bib-0014","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet."},{"key":"2024020318592607700_jbmr2154-bib-0016","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9343(62)90235-8","article-title":"Hyperostosis corticalis generalisata: report of seven cases","volume":"33","author":"Van Buchem","year":"1962","journal-title":"Am J Med."},{"issue":"5","key":"2024020318592607700_jbmr2154-bib-0017","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00439-011-0947-3","article-title":"Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia","volume":"129","author":"Kim","year":"2011","journal-title":"Hum Genet."},{"issue":"29","key":"2024020318592607700_jbmr2154-bib-0018","first-page":"26770","article-title":"He X","volume":"280","author":"Semenov","year":"2005","journal-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor. J Biol Chem."},{"issue":"20","key":"2024020318592607700_jbmr2154-bib-0019","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem."},{"issue":"1","key":"2024020318592607700_jbmr2154-bib-0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2012.10.003","article-title":"LRP5 and LRP6 in development and disease","volume":"24","author":"Joiner","year":"2013","journal-title":"Trends Endocrinol Metab."},{"issue":"4","key":"2024020318592607700_jbmr2154-bib-0021","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell."},{"issue":"12","key":"2024020318592607700_jbmr2154-bib-0022","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJM200209193471216","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med."},{"issue":"20","key":"2024020318592607700_jbmr2154-bib-0023","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N Engl J Med."},{"key":"2024020318592607700_jbmr2154-bib-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bonekey.2012.1","article-title":"LRP5 and bone mass regulation: where are we now","volume":"1","author":"Johnson","year":"2012","journal-title":"Bonekey Rep."},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/368277","article-title":"Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density","volume":"72","author":"Van Wesenbeeck","year":"2003","journal-title":"Am J Hum Genet."},{"issue":"11","key":"2024020318592607700_jbmr2154-bib-0026","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","article-title":"Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity","volume":"21","author":"Ellies","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"50","key":"2024020318592607700_jbmr2154-bib-0027","first-page":"38276","article-title":"He X","volume":"281","author":"Semenov","year":"2006","journal-title":"LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J Biol Chem."},{"issue":"6","key":"2024020318592607700_jbmr2154-bib-0028","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","article-title":"The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations","volume":"82","author":"Balemans","year":"2008","journal-title":"Calcif Tissue Int."},{"issue":"12","key":"2024020318592607700_jbmr2154-bib-0029","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/MCB.25.12.4946-4955.2005","article-title":"Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling","volume":"25","author":"Ai","year":"2005","journal-title":"Mol Cell Biol."},{"issue":"5","key":"2024020318592607700_jbmr2154-bib-0030","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/jcb.22335","article-title":"A cell-based Dkk1 binding assay reveals roles for extracellular domains of LRP5 in Dkk1 interaction and highlights differences between wild-type and the high bone mass mutant LRP5(G171V)","volume":"108","author":"Murrills","year":"2009","journal-title":"J Cell Biochem."},{"issue":"12","key":"2024020318592607700_jbmr2154-bib-0031","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/jbmr.2003","article-title":"Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2","volume":"28","author":"Kogawa","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"32","key":"2024020318592607700_jbmr2154-bib-0032","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.M112.350108","article-title":"Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors","volume":"287","author":"Holdsworth","year":"2012","journal-title":"J Biol Chem."},{"issue":"22","key":"2024020318592607700_jbmr2154-bib-0033","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J Biol Chem."},{"issue":"11","key":"2024020318592607700_jbmr2154-bib-0034","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","article-title":"Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo","volume":"4","author":"Choi","year":"2009","journal-title":"PLoS One."},{"issue":"1","key":"2024020318592607700_jbmr2154-bib-0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.061002","article-title":"Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation","volume":"22","author":"van Bezooijen","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"26","key":"2024020318592607700_jbmr2154-bib-0036","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.M301716200","article-title":"Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity","volume":"278","author":"Kusu","year":"2003","journal-title":"J Biol Chem."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0037","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.bbrc.2011.12.048","article-title":"Robert Bergen H 3rd, Kumar R. The sclerostin-bone protein interactome","volume":"417","author":"Devarajan-Ketha","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0038","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1359\/jbmr.061118","article-title":"PTH stimulates bone formation in mice deficient in Lrp5","volume":"22","author":"Iwaniec","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"33","key":"2024020318592607700_jbmr2154-bib-0039","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M601000200","article-title":"The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment","volume":"281","author":"Sawakami","year":"2006","journal-title":"J Biol Chem."},{"issue":"12","key":"2024020318592607700_jbmr2154-bib-0040","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.040907","article-title":"Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6","volume":"19","author":"Holmen","year":"2004","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0041","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200201089","article-title":"Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor","volume":"157","author":"Kato","year":"2002","journal-title":"J Cell Biol."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0042","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2024020318592607700_jbmr2154-bib-0043","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"35","key":"2024020318592607700_jbmr2154-bib-0044","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1073\/pnas.1007428107","article-title":"Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies","volume":"107","author":"Ettenberg","year":"2010","journal-title":"Proc Natl Acad Sci U S.A."},{"issue":"12","key":"2024020318592607700_jbmr2154-bib-0045","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.1074\/jbc.M109.092130","article-title":"Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6","volume":"285","author":"Bourhis","year":"2010","journal-title":"J Biol Chem."},{"issue":"9","key":"2024020318592607700_jbmr2154-bib-0046","doi-asserted-by":"crossref","first-page":"e12682","DOI":"10.1371\/journal.pone.0012682","article-title":"Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies","volume":"5","author":"Gong","year":"2010","journal-title":"PLoS One."},{"issue":"10","key":"2024020318592607700_jbmr2154-bib-0047","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/jbmr.1946","article-title":"An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: applications in mice with bone property altering Lrp5 mutations","volume":"28","author":"Ayturk","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020318592607700_jbmr2154-bib-0048","doi-asserted-by":"crossref","first-page":"e63323","DOI":"10.1371\/journal.pone.0063323","article-title":"Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition","volume":"8","author":"Riddle","year":"2013","journal-title":"PLoS One."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0049","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ydbio.2011.08.020","article-title":"Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo","volume":"359","author":"Joeng","year":"2011","journal-title":"Dev Biol."},{"issue":"10","key":"2024020318592607700_jbmr2154-bib-0050","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1359\/jbmr.080512","article-title":"Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd","volume":"23","author":"Kubota","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"21","key":"2024020318592607700_jbmr2154-bib-0051","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1242\/dev.01405","article-title":"Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis","volume":"131","author":"Kokubu","year":"2004","journal-title":"Development."},{"issue":"5816","key":"2024020318592607700_jbmr2154-bib-0052","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","article-title":"LRP6 mutation in a family with early coronary disease and metabolic risk factors","volume":"315","author":"Mani","year":"2007","journal-title":"Science."},{"issue":"4","key":"2024020318592607700_jbmr2154-bib-0053","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020318592607700_jbmr2154-bib-0054","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00223-012-9587-4","article-title":"Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper","volume":"90","author":"Goldhahn","year":"2012","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"2024020318592607700_jbmr2154-bib-0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020318592607700_jbmr2154-bib-0056","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr Rev."},{"issue":"1","key":"2024020318592607700_jbmr2154-bib-0057","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/dvdy.22181","article-title":"Wnt modulators in the biotech pipeline","volume":"239","author":"Rey","year":"2010","journal-title":"Dev Dyn."},{"issue":"6097","key":"2024020318592607700_jbmr2154-bib-0058","first-page":"922","article-title":"Cell biology","volume":"337","author":"Lum","year":"2012","journal-title":"The unusual case of Porcupine. Science."},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0059","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bone.2007.05.009","article-title":"Bone mass is inversely proportional to Dkk1 levels in mice","volume":"41","author":"MacDonald","year":"2007","journal-title":"Bone."},{"issue":"6","key":"2024020318592607700_jbmr2154-bib-0060","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass","volume":"21","author":"Morvan","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2024020318592607700_jbmr2154-bib-0061","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","article-title":"Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia","volume":"39","author":"Li","year":"2006","journal-title":"Bone."},{"issue":"11","key":"2024020318592607700_jbmr2154-bib-0062","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.01126","article-title":"Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6","volume":"131","author":"MacDonald","year":"2004","journal-title":"Development."},{"issue":"11","key":"2024020318592607700_jbmr2154-bib-0063","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/nsmb.2139","article-title":"Crystal structures of the extracellular domain of LRP6 and its complex with DKK1","volume":"18","author":"Cheng","year":"2011","journal-title":"Nat Struct Mol Biol."},{"issue":"10","key":"2024020318592607700_jbmr2154-bib-0064","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.str.2011.07.005","article-title":"Wnt antagonists bind through a short peptide to the first beta-propeller domain of LRP5\/6","volume":"19","author":"Bourhis","year":"2011","journal-title":"Structure."},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.081104","article-title":"Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma","volume":"24","author":"Heath","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020318592607700_jbmr2154-bib-0066","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-09-047712","article-title":"Shaughnessy JD Jr. Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo","volume":"109","author":"Yaccoby","year":"2007","journal-title":"Blood."},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0067","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.2008.102046","article-title":"Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints","volume":"69","author":"Uderhardt","year":"2010","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0068","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med."},{"issue":"12","key":"2024020318592607700_jbmr2154-bib-0069","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","article-title":"Control of the SOST bone enhancer by PTH using MEF2 transcription factors","volume":"22","author":"Leupin","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2024020318592607700_jbmr2154-bib-0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10735-007-9096-3","article-title":"Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone","volume":"38","author":"Silvestrini","year":"2007","journal-title":"J Mol Histol."},{"issue":"4","key":"2024020318592607700_jbmr2154-bib-0071","first-page":"358","article-title":"Downregulation of SOST\/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes","volume":"6","author":"Bellido","year":"2006","journal-title":"J Musculoskelet Neuronal Interact."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0072","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone."},{"issue":"4","key":"2024020318592607700_jbmr2154-bib-0073","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tem.2009.12.002","article-title":"Does osteocytic SOST suppression mediate PTH bone anabolism","volume":"21","author":"Kramer","year":"2010","journal-title":"Trends Endocrinol Metab."},{"issue":"8","key":"2024020318592607700_jbmr2154-bib-0074","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/en.2011-0049","article-title":"Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice","volume":"152","author":"Robling","year":"2011","journal-title":"Endocrinology."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1874467211205020153","article-title":"The role of BMPs in bone anabolism and their potential targets SOST and DKK1","volume":"5","author":"Kamiya","year":"2012","journal-title":"Curr Mol Pharmacol."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0076","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bone.2004.04.019","article-title":"Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone."},{"issue":"1","key":"2024020318592607700_jbmr2154-bib-0077","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bone.2013.01.031","article-title":"High-concentration of BMP2 reduces cell proliferation and increases apoptosis via DKK1 and SOST in human primary periosteal cells","volume":"54","author":"Kim","year":"2013","journal-title":"Bone."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0078","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bone.2013.01.018","article-title":"Paradoxical Sost gene expression response to mechanical unloading in metaphyseal bone","volume":"53","author":"Macias","year":"2013","journal-title":"Bone."},{"issue":"1","key":"2024020318592607700_jbmr2154-bib-0079","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bone.2011.10.025","article-title":"Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading","volume":"50","author":"Tu","year":"2012","journal-title":"Bone."},{"issue":"15","key":"2024020318592607700_jbmr2154-bib-0080","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.febslet.2011.06.019","article-title":"Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4","volume":"585","author":"Galea","year":"2011","journal-title":"FEBS Lett."},{"issue":"51","key":"2024020318592607700_jbmr2154-bib-0081","doi-asserted-by":"crossref","first-page":"35939","DOI":"10.1074\/jbc.M109.060335","article-title":"The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity","volume":"284","author":"Bonnet","year":"2009","journal-title":"J Biol Chem."},{"issue":"9","key":"2024020318592607700_jbmr2154-bib-0082","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J Biol Chem."},{"key":"2024020318592607700_jbmr2154-bib-0083","article-title":"Deletion of a single beta-catenin allele in osteocytes abolishes the bone anabolic response to loading","author":"Javaheri","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2024020318592607700_jbmr2154-bib-0084","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.lfs.2013.01.001","article-title":"Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST\/sclerostin in osteocytes","volume":"92","author":"Kim","year":"2013","journal-title":"Life Sci."},{"issue":"6","key":"2024020318592607700_jbmr2154-bib-0085","doi-asserted-by":"crossref","first-page":"e65940","DOI":"10.1371\/journal.pone.0065940","article-title":"HIF-1alpha inhibits Wnt signaling pathway by activating Sost expression in osteoblasts","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One."},{"issue":"12","key":"2024020318592607700_jbmr2154-bib-0086","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1210\/en.2011-1128","article-title":"Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor","volume":"152","author":"Cohen-Kfir","year":"2011","journal-title":"Endocrinology."},{"issue":"13","key":"2024020318592607700_jbmr2154-bib-0087","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1074\/jbc.M112.405456","article-title":"Estrogen receptor alpha mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor beta","volume":"288","author":"Galea","year":"2013","journal-title":"J Biol Chem."},{"issue":"3","key":"2024020318592607700_jbmr2154-bib-0088","first-page":"455","article-title":"Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation","volume":"28","author":"Hie","year":"2011","journal-title":"Int J Mol Med."},{"issue":"2","key":"2024020318592607700_jbmr2154-bib-0089","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2011.09.060","article-title":"Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1","volume":"414","author":"Kamiya","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"key":"2024020318592607700_jbmr2154-bib-0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bonekey.2013.95","article-title":"Clinical utility of serum sclerostin measurements","volume":"2","author":"Clarke","year":"2013","journal-title":"Bonekey Rep."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2154","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/1\/24\/56567880\/jbmr2154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/1\/24\/56567880\/jbmr2154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:51:19Z","timestamp":1710341479000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/29\/1\/24-28\/7599216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,11,28]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2154","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,1,1]]},"published":{"date-parts":[[2013,11,28]]}}}